についてビジネス
ヘルププライバシー用語
概要法的地位タイムラインネットワークオーナーシップ株主一覧実質的支配者地理財務財務健全性書類
概要法的地位タイムラインネットワークオーナーシップ株主一覧実質的支配者地理財務財務健全性書類

COMBAT MEDICAL HOLDINGS LTD

🇬🇧イギリス•Private Limited Company (Ltd.)•アクティブ

概要

国名🇬🇧イギリス
ステータスアクティブ
登録番号10743075
設立27/04/2017
目的その他の持株会社の活動(n.e.c.
住所Lamer House, Lamer Lane, Wheathampstead, AL4 8RL
確認声明次の期限: 10/05/2027; 最後のメークアップ: —

法的地位

法的形式Private Limited Company (Ltd.)
ステータスアクティブ
登録日27/04/2017
登録機関Companies House
登録資本金£27,118

ソース: UK Companies House · 最終更新: 03/12/2025

タイムライン (23イベント)

06/06/2025

年次決算を提出

Accounts for a small company made up to 31 December 2024

ドキュメントでファイルを見る

31/12/2024

年次決算を提出

Annual Accounts · Accounting year ending 31/12/2024

ドキュメントでファイルを見る

27/04/2017

就任 Edward Alexander Bruce-white (人)

Secretaryとして就任

ネットワーク

この図は接続が多くあります。をご利用ください。
Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
ネットワーク深度

オーナーシップ

Persons with significant control

Alberto Martinez

50–75% shares · 50–75% voting rights

就任日: 24/08/2017

62.5%
Edward Alexander Bruce-white

Right to appoint directors

就任日: 27/04/2017

—

Officers & directors

Andrea Giacomo Mica

Director

就任日: 29/10/2019

—
Balint Botond Nemeth

Director

就任日: 29/10/2019

—
Alberto Martinez

Director

就任日: 24/08/2017

—

1件中 5–8件を表示

1 / 2

オーナーシップ・タイムライン (2の変更)

24/08/2017

就任 Alberto Martinez (人)

重要な支配権を持つ者

27/04/2017

就任 Edward Alexander Bruce-white (人)

重要な支配権を持つ者

株主一覧

Holdings (current and historical)

Period名前種別持株FromToSource filing
CurrentEdward Alexander Bruce-white個人167,2822026-04-26—
CurrentAlberto Martinez個人1,330,5042026-04-26—
CurrentArb Systems法人47,1352026-04-26—
CurrentSilvia Martinez個人27,9002026-04-26—
CurrentJamie Poch Arbos個人21,1002026-04-26—
CurrentAlejandro Sousa個人14,9802026-04-26—
CurrentWcs Nominees Limited法人68,2632026-04-26—
CurrentOxford Technology Management Limited法人2,7002026-04-26—
CurrentJames Aird個人52,1992026-04-26—
CurrentRebecca Thwaites個人11,5642026-04-26—
CurrentRonnie Potel個人53,8072026-04-26—
CurrentCentury New Investments Limited法人11,6002026-04-26—
CurrentMary Chiu個人17,0952026-04-26—
CurrentTower Pension Trustees Limited (edward Bruce-white)法人11,6002026-04-26—
CurrentThomas Carlone個人10,5462026-04-26—
CurrentFuntastic Holdings Limited法人28,9362026-04-26—
CurrentJennifer Peng個人5,2732026-04-26—
CurrentArjun Vikram Menon個人23,5112026-04-26—
CurrentAndrew Holmes個人3,0132026-04-26—
CurrentMichael Flynn個人12,0522026-04-26—
CurrentEliza Smith個人21,0212026-04-26—
CurrentNicholas Smith個人11,9822026-04-26—
CurrentNicholas Smith個人1,3302026-04-26—
CurrentMichael Morell個人1,8002026-04-26—
CurrentLaurence Rosenfeld Revocable Trust Dated Dec 30 1999法人1,6462026-04-26—
CurrentBy Rosaig Equity Partners Gp, Llc, Its General Partner Rosaig Equity Partners Lp法人1,6462026-04-26—
HistoricalKenneth Pelton個人7,0922026-04-26—
HistoricalCharles Ng個人7,0922026-04-26—
HistoricalTucker Montana Highfield個人5,3212026-04-26—
HistoricalDaven Ashok Patel個人3,5462026-04-26—
HistoricalJonathan Chung Shing Cheng個人4,9652026-04-26—
HistoricalRichard Max Cohen個人3,7082026-04-26—
HistoricalSurgawi Investments Limited法人12,9482026-04-26—
HistoricalJason Swamy個人3,5462026-04-26—
HistoricalMax Stuedlein個人1,7732026-04-26—
HistoricalPranitan Phornprapha個人7,0922026-04-26—
HistoricalTower Pension Trustees Limited (diane Korda Hewitt)法人4,8202026-04-26—
HistoricalEternal Eight Limited法人3,5502026-04-26—
HistoricalDarley Abbey Investments Limited法人18,1922026-04-26—
HistoricalGeoffrey Francis Traylen個人8502026-04-26—
HistoricalAshley Hooper個人1,0642026-04-26—
HistoricalAlexis Adamczyk個人7,4452026-04-26—
HistoricalPhilippe Lenoble個人5,0002026-04-26—
HistoricalRobin Goodfellow個人3,7002026-04-26—
HistoricalHugh Smith個人3,5102026-04-26—
HistoricalJulia Smith個人7002026-04-26—
HistoricalJonathan Hufford個人7,0902026-04-26—
HistoricalKatrina Maria Santos Razon個人14,1842026-04-26—
HistoricalRoger Bruce-white個人3,1032026-04-26—
HistoricalFrances Bruce-white個人3,1032026-04-26—
HistoricalWilliam Mcculloch個人1,0002026-04-26—
HistoricalMartyn James Aguss個人1,0642026-04-26—
HistoricalGraeme Francis Cooper個人1,4192026-04-26—
HistoricalHelen Bo King Cooper個人1,4192026-04-26—
HistoricalSimon Fraser Robertson Ross個人7102026-04-26—
HistoricalRichard Bednarek個人1,5002026-04-26—
HistoricalPhilip Morley個人7102026-04-26—
HistoricalNambod Investments法人24,8232026-04-26—
HistoricalMargarita Salcedo個人7122026-04-26—
HistoricalJorge Salcedo個人9002026-04-26—
HistoricalTenbrinke Teravest個人1,7732026-04-26—
HistoricalYosoturo S.l.法人2,9552026-04-26—
HistoricalTusutura S.l.法人2,9552026-04-26—
HistoricalActa Salvatore個人41,9002026-04-26—
HistoricalVenture Founder Nominee Limited法人24,2062026-04-26—
HistoricalT&j Meyer Family Foundation Ltd法人221,6302026-04-26—
HistoricalJohn Spiers個人35,4602026-04-26—
HistoricalDavid Andrew Mayes個人31,7502026-04-26—
HistoricalHarry Hyman個人4,4322026-04-26—
HistoricalBalint Nemeth個人2,2162026-04-26—
HistoricalJonathan Raoul Hughes個人11,0812026-04-26—
HistoricalCatherine Hughes個人11,0812026-04-26—
HistoricalOlivia Alexandra Roden個人2,2162026-04-26—
HistoricalGeorge Ittmann個人2,2162026-04-26—
HistoricalThe Hatvany Trust法人4,4322026-04-26—
HistoricalPaulo Henrique Thomaz個人26,7002026-04-26—
HistoricalDavid Vessey個人4,4322026-04-26—
HistoricalMichael Vessey個人4,4332026-04-26—
HistoricalCaroline (janet) Banszky個人1,3502026-04-26—
HistoricalAmelia Ann Ballantyne個人1,2002026-04-26—
HistoricalJonathan Har-ewen個人2222026-04-26—
HistoricalInga Hrefna Nicholas個人8872026-04-26—
HistoricalStephen Schick個人7502026-04-26—
HistoricalDuncan Hill個人2002026-04-26—
HistoricalEvomed S.l.法人12,5652026-04-26—
HistoricalSian Nicol個人6202026-04-26—
HistoricalEuroblue Investments Ltd法人48,7592026-04-26—
HistoricalTrustees Of The Priory Foundation法人34,8502026-04-26—
HistoricalBeverly Hurley個人4,4322026-04-26—
HistoricalLily Menon個人119,0302026-04-26—
HistoricalLady Xiaofen Aird個人64,6992026-04-26—
HistoricalAndrew Kieren Smith個人1,7502026-04-26—
HistoricalHelen Louise Smith個人1,7502026-04-26—
HistoricalJohn Charles Ruskin個人4,4322026-04-26—
HistoricalLaurent Benarroch個人2,6592026-04-26—
HistoricalJerome Bassot個人13,2982026-04-26—
HistoricalMahesh Collins個人4,4322026-04-26—
HistoricalDerek Harmon個人4,8522026-04-26—
HistoricalAmitav, Trustee Under The Amitav Mehra Trust, Date Mehra法人1,6462026-04-26—
HistoricalGian P And Myriam, Trustees Under The Dilawari Family Trust法人1,6462026-04-26—
HistoricalJoseph Nartore個人1,6462026-04-26—
HistoricalJason, Trustee Of The Spartan Trust Dated November 1999法人5,0002026-04-26—
HistoricalPoul Strange個人5,0002026-04-26—
HistoricalNw Angel Fund 1 Lp法人6,6042026-04-26—
HistoricalJohn Abeles個人1,9542026-04-26—
HistoricalBy: Varia Ventures Management Company Llc, Varia Fund 001, A Series Of Sinc Master Fund, Llp法人3,2722026-04-26—
HistoricalBy: Varia Ventures Management Company Llc, Varia Fund 001, A Series Of Aga-varia Master Llc法人6,5452026-04-26—

資本金

Total shares167,282
ClassORDINARY
Nominal value0.01 GBP
Unpaid0
最終確認日2026-05-10
Validation2026-05-10

実質的支配者

名前持株国以降
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

地理

本社

Lamer House

Lamer Lane

Wheathampstead

AL4 8RL

財務

主な数値は年次決算提出資料より。

通貨を変換

2019

利益/(損失): £-91.1K

主な数字

利益/(損失)

2017—
2019£-91,081
2020£-8,661
2021£-95,492
2022£-69,078
2023£-139,714
2024£-118,251

総資産

2017£30,784,281
2019£30,785,073
2020£0
2021£0
2022£2
2023£2
2024£4

Net Assets Liabilities

2017—
2019—
2020—
2021—
2022£4,652,069
2023£5,582,174
2024£5,451,150

Equity

2017£30,784,281
2019£30,785,073
2020£0
2021£4,652,069
2022£4,652,069
2023£5,451,150
2024£268

Share Capital

2017—
2019—
2020—
2021—
2022—
2023—
2024£27,118

Current Assets

2017—
2019£1,342,323
2020£3,852,977
2021£3,837,795
2022£4,811,415
2023£6,153,556
2024£5,959,873

Net Current Assets Liabilities

2017£-1,010
2019£1,226,827
2020£3,789,352
2021£3,780,691
2022£4,651,778
2023£5,949,938
2024£5,705,667

Total Assets Less Current Liabilities

2017£30,784,281
2019£32,012,118
2020£3,789,570
2021£3,780,909
2022£4,652,069
2023£5,950,229
2024£5,705,958

Cash Bank On Hand

2017£485
2019£99,990
2020£1,329,220
2021£722,452
2022£574,431
2023£965,256
2024£19,191

Debtors

2017—
2019£1,242,333
2020£2,523,757
2021£3,115,343
2022£4,236,984
2023£5,188,300
2024£5,940,682

Other Debtors

2017—
2019—
2020£4,854
2021—
2022—
2023£0
2024£8,367

Creditors

2017£1,495
2019£115,496
2020£63,625
2021£57,104
2022£159,637
2023£203,618
2024£254,206

Trade Creditors Trade Payables

2017—
2019—
2020£61,786
2021£49,991
2022£88,476
2023£78,425
2024£134,415

Other Creditors

2017—
2019—
2020£1,839
2021£1,870
2022—
2023—
2024—

Investments Fixed Assets

2017£30,785,291
2019£30,785,291
2020£218
2021£218
2022£291
2023£291
2024£291

Investments In Group Undertakings Participating Interests

2017—
2019—
2020£218
2021£218
2022£291
2023£291
2024£291

Issue Equity Instruments

2017—
2019—
2020—
2021£900,257
2022£986,057
2023£986,048
2024£394,692

Number Shares Issued Fully Paid

20172,183,354
20192,509,226
2020—
2021—
2022—
2023—
20242,677,014

Par Value Share

2017£0
2019£0
2020—
2021—
2022—
2023—
2024£0

Accrued Liabilities Deferred Income

2017£750
2019—
2020—
2021—
2022—
2023—
2024—

Amounts Owed By Related Parties

2017—
2019—
2020£2,518,903
2021£3,115,343
2022£4,236,984
2023£5,188,300
2024£5,932,315

Number Equity Instruments Exercisable Share-based Payment Arrangement

2017—
2019—
2020—
2021290,652
2022427,648
2023455,941
2024487,976

Number Equity Instruments Granted Share-based Payment Arrangement

2017—
2019—
20200
2021237,947
20221,843
202354,703
2024493

Number Equity Instruments Outstanding Share-based Payment Arrangement

2017—
2019—
2020—
2021290,652
2022528,599
2023512,835
2024536,853

Other Remaining Borrowings

2017—
2019—
2020—
2021—
2022£0
2023£368,055
2024£254,808

Other Taxation Social Security Payable

2017—
2019—
2020£0
2021£5,243
2022£6,096
2023£8,365
2024£2,543

Percentage Class Share Held In Subsidiary

2017—
2019—
2020£1
2021£1
2022—
2023—
2024£0

Weighted Average Exercise Price Equity Instruments Exercisable Share-based Payment Arrangement

2017—
2019—
2020—
2021£4
2022£3
2023£3
2024£4

Weighted Average Exercise Price Equity Instruments Expired Share-based Payment Arrangement

2017—
2019—
2020—
2021£0
2022£2
2023£2
2024£0

Weighted Average Exercise Price Equity Instruments Forfeited Share-based Payment Arrangement

2017—
2019—
2020—
2021—
2022—
2023£0
2024£4

Weighted Average Exercise Price Equity Instruments Granted Share-based Payment Arrangement

2017—
2019—
2020£0
2021£2
2022£4
2023£4
2024£11

Weighted Average Exercise Price Equity Instruments Outstanding Share-based Payment Arrangement

2017—
2019—
2020—
2021£4
2022£3
2023£3
2024£3
メートル2017201920202021202220232024
利益/(損失)—£-91,081£-8,661£-95,492£-69,078£-139,714£-118,251
総資産£30,784,281£30,785,073£0£0£2£2£4
Net Assets Liabilities————£4,652,069£5,582,174£5,451,150
Equity£30,784,281£30,785,073£0£4,652,069£4,652,069£5,451,150£268
Share Capital——————£27,118
Current Assets—£1,342,323£3,852,977£3,837,795£4,811,415£6,153,556£5,959,873
Net Current Assets Liabilities£-1,010£1,226,827£3,789,352£3,780,691£4,651,778£5,949,938£5,705,667
Total Assets Less Current Liabilities£30,784,281£32,012,118£3,789,570£3,780,909£4,652,069£5,950,229£5,705,958
Cash Bank On Hand£485£99,990£1,329,220£722,452£574,431£965,256£19,191
Debtors—£1,242,333£2,523,757£3,115,343£4,236,984£5,188,300£5,940,682
Other Debtors——£4,854——£0£8,367
Creditors£1,495£115,496£63,625£57,104£159,637£203,618£254,206
Trade Creditors Trade Payables——£61,786£49,991£88,476£78,425£134,415
Other Creditors——£1,839£1,870———
Investments Fixed Assets£30,785,291£30,785,291£218£218£291£291£291
Investments In Group Undertakings Participating Interests——£218£218£291£291£291
Issue Equity Instruments———£900,257£986,057£986,048£394,692
Number Shares Issued Fully Paid2,183,3542,509,226————2,677,014
Par Value Share£0£0————£0
Accrued Liabilities Deferred Income£750——————
Amounts Owed By Related Parties——£2,518,903£3,115,343£4,236,984£5,188,300£5,932,315
Number Equity Instruments Exercisable Share-based Payment Arrangement———290,652427,648455,941487,976
Number Equity Instruments Granted Share-based Payment Arrangement——0237,9471,84354,703493
Number Equity Instruments Outstanding Share-based Payment Arrangement———290,652528,599512,835536,853
Other Remaining Borrowings————£0£368,055£254,808
Other Taxation Social Security Payable——£0£5,243£6,096£8,365£2,543
Percentage Class Share Held In Subsidiary——£1£1——£0
Weighted Average Exercise Price Equity Instruments Exercisable Share-based Payment Arrangement———£4£3£3£4
Weighted Average Exercise Price Equity Instruments Expired Share-based Payment Arrangement———£0£2£2£0
Weighted Average Exercise Price Equity Instruments Forfeited Share-based Payment Arrangement—————£0£4
Weighted Average Exercise Price Equity Instruments Granted Share-based Payment Arrangement——£0£2£4£4£11
Weighted Average Exercise Price Equity Instruments Outstanding Share-based Payment Arrangement———£4£3£3£3

書類

Confirmation statement

10/05/2026

表示

ドキュメントAI

近日公開

Companexia Document AI

提出書類や抄本について質問できます。AIが文書を読み、文脈に沿って回答します(近日公開)。

Change of details for person with significant control

30/03/2026

表示

Return of allotment of shares

23/12/2025

表示

Accounts for a small company made up to 31 December 2024

06/06/2025

表示

Confirmation statement

13/05/2025

表示

Return of allotment of shares

14/04/2025

表示

Change of details for person with significant control

01/04/2025

表示

Annual Accounts

会計期間終了日: 31/12/2024

ファイルされた31/12/2024

表示

Return of allotment of shares

29/11/2024

表示

1件中 10–51件を表示

1 / 6

他の企業・人物を閲覧

🇮🇪KILDALE LIMITED🇮🇪BRAMBURY LIMITED🇮🇪CLOVERWOOD LIMITED🇬🇧Mrs Melissa Alice Field🇬🇧CLAYTON, Edward James🇬🇧Mr Jonathan Richard Norris
損益 前年比(2023 vs 2024)損益 前年比
+15.4%
ROA(当期純利益)(2024)ROA(当期純利益)
-3,368,974.4%
自己資本比率(2024)自己資本比率
7,635.3%
総資産 前年比(2023 vs 2024)総資産 前年比
+102.9%
総資産 CAGR(2017–2024)総資産 CAGR
-93%

財務健全性

決算書から算出した比率です。データがない、または意味をなさない場合は表示しません。

成長

流動純資産 前年比(2017 vs 2019)
+121,568%
損益 前年比(2019 vs 2020)
+90.5%
総資産 前年比(2019 vs 2020)
-100%
流動純資産 前年比(2019 vs 2020)
+208.9%
損益 前年比(2020 vs 2021)
-1,002.6%
流動純資産 前年比(2020 vs 2021)
-0.2%
損益 前年比(2021 vs 2022)
+27.7%
  1. –
  2. –
  3. –COMBAT MEDICAL HOLDINGS LTD
流動純資産 前年比(2021 vs 2022)
+23%
損益 前年比(2022 vs 2023)
-102.3%
総資産 前年比(2022 vs 2023)
-14.4%
流動純資産 前年比(2022 vs 2023)
+27.9%
損益 前年比(2023 vs 2024)
+15.4%
総資産 前年比(2023 vs 2024)
+102.9%
流動純資産 前年比(2023 vs 2024)
-4.1%
総資産 CAGR(2017–2024)
-93%

効率・収益性

ROA(当期純利益)(2019)
-0.3%
ROA(当期純利益)(2022)
-3,419,703%
ROA(当期純利益)(2023)
-8,075,953.8%
ROA(当期純利益)(2024)
-3,368,974.4%

運転資本・流動性

流動純資産(2017)
-£1,010
流動純資産(2019)
£1,226,827
流動純資産(2020)
£3,789,352
流動純資産(2021)
£3,780,691
流動純資産(2022)
£4,651,778
流動純資産(2023)
£5,949,938
流動純資産(2024)
£5,705,667

資本構成

自己資本比率(2017)
100%
自己資本比率(2019)
100%
自己資本比率(2022)
230,300,445.5%
自己資本比率(2023)
315,095,375.7%
自己資本比率(2024)
7,635.3%
ホーム
イギリス
Wheathampstead